VRC07-523LS: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving VRC07-523LS

• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 36 locations
• RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
  NCT06484335 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• The Tatelo Plus Study
  NCT06508749 · Phase: Phase 1, Phase 2 · Ages: 24 Weeks to 25 Years · Sex: All (male and female) · 2 locations
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · 46 locations

Common questions

How many recruiting trials involve VRC07-523LS?

4 recruiting trials across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.